Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jo Anne Zujewski

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Proposal for the use of progression-free survival in unblinded randomized trialsBoris Freidlin, Edward L Korn, Sally Hunsberger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancerJennifer Eng-Wong, Stephen D Hursting, David Venzon, et al.
Journal of Global Oncology|September 23, 2018
Knowledge Summaries for Comprehensive Breast Cancer ControlJo Anne Zujewski, Allison L Dvaladze, Andre Ilbawi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2006
Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancerJessica M Faupel-Badger, Sheila A Prindiville, David Venzon, et al.
Journal of Global Oncology|September 23, 2018
Building a Network of Health Professionals for Breast and Cervical Cancer Control in the Andean RegionDiana Mendoza-Cervantes, Isabel Otero, Jo Anne Zujewski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2008
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancerJennifer Eng-Wong, Jennifer Orzano-Birgani, Catherine K Chow, et al.
Journal of Global Oncology|September 23, 2018
Sentinel Lymph Node Biopsy Pathology and 2-Year Postsurgical Recurrence of Breast Cancer in Kenyan WomenNathan R Brand, Ronald Wasike, Khalid Makhdomi, et al.
Breast Cancer Research and Treatment|October 9, 2003
A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancerJo Anne Zujewski, Jennifer Eng-Wong, Joyce O'Shaughnessy, et al.
Cancer|May 10, 2007
The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technologyAmy Rapkiewicz, Virginia Espina, Jo Anne Zujewski, et al.
Breast Cancer Research and Treatment|December 17, 2009
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancerLarissa A Korde, Lara Lusa, Lisa McShane, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Proposal for the use of progression-free survival in unblinded randomized trialsBoris Freidlin, Edward L Korn, Sally Hunsberger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancerJennifer Eng-Wong, Stephen D Hursting, David Venzon, et al.
Journal of Global Oncology|September 23, 2018
Knowledge Summaries for Comprehensive Breast Cancer ControlJo Anne Zujewski, Allison L Dvaladze, Andre Ilbawi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2006
Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancerJessica M Faupel-Badger, Sheila A Prindiville, David Venzon, et al.
Journal of Global Oncology|September 23, 2018
Building a Network of Health Professionals for Breast and Cervical Cancer Control in the Andean RegionDiana Mendoza-Cervantes, Isabel Otero, Jo Anne Zujewski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2008
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancerJennifer Eng-Wong, Jennifer Orzano-Birgani, Catherine K Chow, et al.
Journal of Global Oncology|September 23, 2018
Sentinel Lymph Node Biopsy Pathology and 2-Year Postsurgical Recurrence of Breast Cancer in Kenyan WomenNathan R Brand, Ronald Wasike, Khalid Makhdomi, et al.
Breast Cancer Research and Treatment|October 9, 2003
A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancerJo Anne Zujewski, Jennifer Eng-Wong, Joyce O'Shaughnessy, et al.
Cancer|May 10, 2007
The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technologyAmy Rapkiewicz, Virginia Espina, Jo Anne Zujewski, et al.
Breast Cancer Research and Treatment|December 17, 2009
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancerLarissa A Korde, Lara Lusa, Lisa McShane, et al.
Pageof 4